Casey Butler, MD
Pain Medicine · Rochester, MNNPI 1174902977
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,881 of the $3,291 with a category attached, or 87.5%. 17 manufacturers reported payments, led by Medtronic at 42.6% of the total. Reporting peaked in 2022 at $1,312 and has fallen 93.8% since, to $81 in 2025.
Across 60 payments — averaging $54.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Nevro Corp.$986
- Stryker$191
- Merck$170
- SPR Therapeutics, Inc$92
- Averitas Pharma Inc.$81
- plus $369 from 11 others
What the payments were for
- Travel & lodging$2006%
- Food & beverage$2,88188%
- Education$2106%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 17 | $1,402 |
| Nevro Corp. | 14 | $986 |
| Stryker | 2 | $191 |
| Merck | 5 | $170 |
| SPR Therapeutics, Inc | 3 | $92 |
| Averitas Pharma Inc. | 4 | $81 |
| Avanos Medical | 1 | $76 |
| Saluda Medical Americas, Inc. | 2 | $52 |
| Boston Scientific | 1 | $41 |
| Scilex Pharmaceuticals Inc. | 2 | $40 |
| GRT US Holding, Inc. | 2 | $36 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $32 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| Globus Medical | 1 | $20 |
| Aesculap, Inc. | 1 | $18 |
| Kls-martin L.p. | 1 | $18 |
| Bioventus LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Omnia$645
- INTELLIS$451
- INTELLIS ADAPTIVESTIM$240
- SPINEJACK$157
- SYNCHROMED$149
- VANTA ADAPTIVESTIM$123
- BRIDION$121
How this compares
$3,291 in reported general payments places this provider in the 60th percentile of 88 pain medicine providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 29 | $1,151 |
| Duloxetine Hcl | 123 | $1,129 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 52 | $888 |
| Gabapentin | 35 | $646 |
| Tizanidine Hcl | 53 | $604 |
| Pregabalin | 25 | $373 |
| Baclofen | 20 | $312 |
| Cyclobenzaprine Hcl | 21 | $292 |
| Oxycodone Hcl | 13 | $155 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Rochester
- Jonathan HagedornRochester$83K
- Michael McEntireRochester$70K
- Ryan D SouzaRochester$21K
- James WatsonRochester$7K
- Yeng HerRochester$5K
- Laura Matzke BittermanRochester$5K
- Elliot BlankespoorRochester$3K
- Sierra McLeanRochester$2K
- Colin RockRochester$1K
- Michael BiesRochester$881
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.